Skip Navigation LinksDrugRecalls

Top Menu
Left Menu

Food and Drug Branch (FDB)

FDB Home Page

Back to FDB’s Home Page

Contact

Main Telephone:

(800) 495-3232

 

Email:

FDBinfo@cdph.ca.gov

 

Address (Courier Delivery):

California Department of Public Health - Food and Drug Branch

1500 Capitol Ave, MS 7602

Sacramento, CA 95814

 

Address (Non-Courier Delivery):

California Department of Public Health - Food and Drug Branch

P.O. Box 997435, MS 7602

Sacramento, CA 95899

Drug Recalls

Information regarding drug recalls, distribution lists, and links to other drug recall information may be found below. To access previous Drug Recalls, please email FDBMedDevice@cdph.ca.gov or contact us using the information on the left.​

Drug Recall Information

2025 Recalls

FDA Recall: Zicam Cold Remedy Nasal Swabs, Zicam Nasal AllClear Swabs, and Orajel Baby Teething Swabs​ (PDF)

FDA Recall: Amneal Pharmaceutical LLC Issues a Nationwide Recall of Sulfamethoxazole/Trimethoprim Tablets (PDF)​

2024 Recalls

FDA Recall: B. Braun Issues Voluntary Nationwide Recall of 0.9% Sodium Chloride for Injection USP 1000 mL in E3 Containers​ (PDF)​

FDA Recall: Baxter Issues Voluntary Nationwide Recall of One Lot of Heparin Sodium 0.9% Sodium Chloride Injection Due to Potential for Elevated Endotoxin Levels​ (PDF)​

FDA Recall: Hikma Pharmaceuticals USA Inc. Extends Voluntary Nationwide Recall of One Lot of Acetaminophen Injection, 1000mg/100mL (10mg/mL) Bags​ (PDF)​

FDA Recall: Guru Inc., Issues Voluntary Nationwide Recall of Infla-650 Herbal Dietary Supplement Capsules (PDF)​​

FDA Recall: Glenmark Pharmaceuticals Inc., USA Issues Voluntary Nationwide Recall for Potassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K Due to Failed Dissolution (PDF)​

2023 Recalls

FDA Recall: Hospira, Inc. Issues a Voluntary Nationwide Recall for 4.2% Sodium Bicarbonate Injection, USP and 1% and 2% Lidocaine HCl Injection, USP Due to the Potential for Presence of Glass Particulate Matter (PDF)​​

FDA Recall: ​FDA warns consumers not to purchase or use certain methylsulfonylmethane (MSM) eye drops due to contamination (PDF)​

FDA Recall: Global Pharma Healthcare Issues Voluntary Nationwide Recall of Artificial Tears Lubricant Eye Drops Due to Possible Contamination​​

Safety Alerts

FDA Safety Alert: Bone Matrix Product: FDA Safety Communication - Important Information for Human Cell, Tissue and Cellular and Tissue-based Product (HCT/P) Establishments Regarding Tuberculosis Outbreaks ​​

External Links to Recall Information

U.S. FDA Drug Recall Page

To access previous Drug Recalls prior to the last three years, please email FDBMedDevice@cdph.ca.gov or contact us using the information on the left.

Page Last Updated :